** Australia-listed shares of a2 Milk A2M.AX down 0.7% at A$8.47
** Citi says food tech firm Clover's strong 1H25 results suggests positive near-term outlook for infant formula sector
** Clover, an infant formula ingredient supplier, logs HY net profit after tax A$2.4 million ($1.53 million) vs loss A$0.6 mln last year
** Citi flags recovery of infant formula business in Europe and ANZ in Clover's results
** A2's execution has been strong in recent years when the birth rate was declining and domestic brands were taking share; both of those headwinds have now turned to tailwinds - Citi
** Citi also expects new market gains for a2 Milk as co accelerates new product development
** Brokerage maintains "Buy" rating and price target A$8.2
** Stock up 46.5% YTD, including current session's moves
($1 = 1.5723 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.